LZ

Lianshan Zhang

JC Jiangsu Hengrui Medicine Co.: 6 patents #3 of 84Top 4%
SC Shanghai Hengrui Pharmaceutical Co.: 3 patents #3 of 49Top 7%
SC Suzhou Suncadia Biopharmaceuticals Co.: 1 patents #1 of 5Top 20%
Overall (2021): #21,781 of 548,734Top 4%
6
Patents 2021

Issued Patents 2021

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDate
11208484 Use of combination of anti-PD-1 antibody and VEGFR inhibitor in preparation of drug for treating cancers Xing Sun, Guoqing CAO, Changyong Yang, Yong Guo 2021-12-28
11155617 LAG-3 antibody, antigen-binding fragment thereof, and pharmaceutical application thereof Zhuoxiao CAO, Yayuan FU, Qiyue Hu, Weikang Tao, Piaoyang Sun 2021-10-26
11065239 Use of EZH2 inhibitor combined with BTK inhibitor in preparing drug for treating tumor Ke Ma, Guoqing CAO, Changyong Yang 2021-07-20
11000518 Use of combination of VEGFR inhibitor and PARP inhibitor in preparation of medicament for treating gastric cancer Jiahua Jiang, Guoqing CAO, Changyong Yang, Jianjun ZOU, Piaoyang Sun 2021-05-11
10905743 Interleukin 15 protein complex Xiangdong QU, Xin Ye, Qiyue Hu, Dongbing Cui, Weikang Tao +1 more 2021-02-02
10899837 B7-H3 antibody, antigen-binding fragment thereof and medical use thereof Jinming Gu, Xiaohua Wang, Xin Ye, Liuqing Yang, Ting Zhang +1 more 2021-01-26